TwinStrand Biosciences nabs $50m Series B

TwinStrand Biosciences, a developer of duplex sequencing, has closed $50 million in Series B financing.

TwinStrand Biosciences, a developer of duplex sequencing, has closed $50 million in Series B financing. Section 32 led the round with participation from other investors that included Soleus Capital, Janus Henderson Investors, Madrona Venture Group, Ridgeback Capital, and Alexandria Venture Investments.

Source: Press Release